Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
This study is currently recruiting participants.
Verified April 2013 by Fred Hutchinson Cancer Research Center
Sponsor:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Collaborators:
GlaxoSmithKline
National Comprehensive Cancer Network
Information provided by:
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01413113
First received: July 20, 2011
Last updated: April 19, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |